Blue Barn Wealth’s AstraZeneca AZN Stock Holding History

Blue Barn Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,452	Closed	-$376K	–	63
2025 Q3	$376K	Buy	+2,452	New	+$371K	0.17%	90
2025 Q2	–	Sell	-1,369	Closed	-$201K	–	158
2025 Q1	$201K	Buy	+1,369	New	+$198K	0.1%	143
2024 Q4	–	Sell	-1,752	Closed	-$273K	–	152
2024 Q3	$273K	Buy	1,752 +68	+4%	+$11K	0.14%	112
2024 Q2	$263K	Buy	1,684 +165	+11%	+$24.8K	0.15%	99
2024 Q1	$206K	Buy	1,519 +7	+0.5%	+$927	0.11%	126
2023 Q4	$204K	Buy	+1,512	New	+$197K	0.12%	121

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blue Barn Wealth's AZN Position: Q4 2025 in Review

Blue Barn Wealth sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 2,452 shares — an estimated $376K sold.

Blue Barn Wealth first reported a position in AZN in Q4 2023 and held it in 6 quarters. The position peaked at $376K in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Blue Barn Wealth reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Blue Barn Wealth sold 2,452 AstraZeneca shares in Q4 2025, an estimated $376K.
Blue Barn Wealth first reported a position in AstraZeneca in Q4 2023 and held it in 6 quarters.
Blue Barn Wealth's AstraZeneca position peaked at $376K in Q3 2025.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Blue Barn Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.